The Scientific and Research Team at Neuropathix is responsible for advancing the company's pain management therapeutic pipeline. This includes conducting cutting-edge research, developing new drug formulations, validating experimental data, and ensuring that all scientific activities align with regulatory standards and the company's strategic objectives.
Charles L. Loprinzi
Scientific Advisor
Daniel Richman
Scientific Advisor
Daniele Piomelli
Scientific Advisor
Douglas Brenneman
Chief Pharmacologist
Jason Clement
Scientific Advisor
Mark McDonnell
Chief Chemist
Michael Ropacki
Scientific Advisor
Ryan Turner
Scientific Advisor
William A. Kinney
Chief Scientific Officer
View all